Collaboration supports entry of BRI’s high performance feed enzyme products in South Asia through exclusive distribution rights to Jubilant
Research Triangle Park, N.C./ Noida, India—September 30, 2014—BioResource International, Inc. (BRI), a global biotechnology company specializing in the research, development and manufacture of high-performance, cost effective enzyme solutions for animal nutrition, has signed a marketing agreement with Jubilant Life Sciences, an integrated pharmaceutical and life sciences company, for marketing and distribution of selected feed enzyme products in South Asia.
Jubilant, recognized as the second largest manufacturer of Vitamin B3 (Niacin and Niacinamide) in the world and for its leadership in vitamins for the animal nutrition market, will be the exclusive marketing partner of BRI’s Xylamax™ and XylaQuick™ products in South Asia. Jubilant will market and distribute Xylamax and XylaQuick to large volume poultry producers, feed integrators, and animal health and nutrition consultants throughout India, Pakistan, Sri Lanka, Nepal, Bangladesh and Bhutan.
“The addition of Jubilant Life Sciences to our alliance of global business partners marks the beginning of the next phase of our strategic growth plan,” said Dr. Giles Shih, CEO, BRI. “We look forward to a successful, long-term partnership with Jubilant and their customers in the South Asia market.”
Xylamax, BRI’s newest product, is an intrinsically thermo-stable xylanase feed enzyme delivering consistent, all-around performance in both nutrient release and absorption. It has been scientifically proven to help producers optimize animal nutrition safely and sustainably. The unique XylaQuick (Xylamax Qualitative In-feed Colorimetric Kit) test allows for easy, on-site testing to confirm that Xylamax has been added and properly distributed within the animal feed.
“Strategically, it is a very positive development for us. Jubilant is a significant player in the nutrition market and manufactures a wide range of Nutrition Ingredients for application across feed, food, pharmaceutical, agrochemical, technical and personal care. We are already present in the animal nutrition segment through a range of feed additives. We are happy with our association with BRI as it will help us accelerate and expand our product portfolio into enzymes,” said Mr. Pramod Yadav, CEO, Advance Intermediates and Nutritional Products, Jubilant Life Sciences.
“BRI, with its expertise in the design and development of safe, effective and economical enzyme solutions, made an appealing partner consistent with our corporate commitment to long-term sustainability through reduced environmental footprint,” added Mr. Yadav.
Global demand for poultry is on the rise, and increased profits are expected, particularly in South Asia and the Indian subcontinent. According to Investment Information And Credit Rating Agency of India (ICRA), Indian poultry sector has been growing at around 8-10 per cent annually over the last decade with broiler meat volumes growing at more than 10 per cent, while table egg which is growing at 5-6 per cent is mainly driven by increased domestic consumption.
“Partnering with Jubilant provides BRI an important strategic opportunity to showcase our newest enzyme solution, Xylamax, in the South Asia market,” commented Julian Young, Chief Operating Officer, BRI. “This partnership brings together two like-minded companies, both committed to managing rising feed costs and feed ingredient quality variations in a way that is safe for animals, humans and the environment
BRI is a global biotechnology company specializing in the research, development and manufacture of high-performance enzymes that help poultry and swine producers optimize animal nutrition. Founded in 1999, BRI continues to build on its reputation as a team of trusted enzyme experts that utilizes its extensive knowledge in biotechnology to transform the natural power of enzymes into safe, economical and sustainable animal nutrition solutions. BRI has successfully developed and commercialized a portfolio of products, including Versazyme®, Valkerase®and Xylamax™. The company’s premier product, Versazyme, has become the leading protease feed enzyme in the global animal nutrition market due to its consistently superior performance across a wide range of feedstuffs. BRI products are designed, developed and tested in the U.S. to comply with stringent global quality and safety standards, including GMP and FAMI-QS. For more information on BRI and its high-performance enzyme solutions, please visit http://briworldwide.com/.
About Jubilant Life Sciences
Jubilant Life Sciences Limited is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. It also provides services in Contract Manufacturing of Sterile Injectables and Drug Discovery and Development. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities in India, US and Canada and a team of around 6200 multicultural people across the globe, the Company is committed to deliver value to its customers spread across over 100 countries. The Company is well recognized as a ‘Partner of Choice’ by leading pharmaceuticals and life sciences companies globally. For more info: www.jubl.com
Crossroads PR & Marketing, for BioResource International, Inc.
For Jubilant Life Sciences
Jubilant Life Sciences Limited
Ph: +91-120 436 1067
Ph: +91 firstname.lastname@example.org
James Tyus Brings Additional Nutrition and Biotechnology Expertise to BRI’s Growing Team of Trusted Enzyme Experts Research Triangle Park, N.C.—August 05, 2014—BioResource International, Inc. (BRI), a global biotechnology firm specializing in the research and development of high-performance enzyme solutions for animal nutrition, is expanding their scientific team with the addition of James Tyus. Tyus holds a doctorate in biological sciences from Tennessee State University, with specialization in agricultural biotechnology and molecular biology. While in graduate school, Tyus held the position of National Student Director with the Poultry Science Association. His academic research in the area of poultry nutrition and genomics has been published in peer-reviewed journals including Poultry Science and the Journal of Poultry Science. Prior to joining BRI, Tyus served as an agricultural science policy analyst in the Washington, D.C. office of Rep. Jeff Fortenberry. In this capacity, Tyus conducted research and provided scientific advice to legislators during the development of the 2014 Agricultural Appropriations Bill and Farm Bill Amendments, and was responsible for coordination with governmental agencies including the USDA and FDA. “We are very pleased to welcome James to the BRI team,” said Dr. JJ Wang, Senior Vice President and Chief Technology Officer at BRI. “James brings a wide array of expertise in biotechnology and broad experience working with avian species. In addition, his work with the Poultry Science Association has allowed him to develop relationships with many leaders in academic and corporate institutions, which will bring added value to our team.” About BRI BRI is a global biotechnology firm specializing in the research, development and manufacture of high-performance enzymes that help poultry and swine producers optimize animal nutrition. Founded in 1999, BRI has gained a reputation as a team of trusted enzyme experts who utilize their extensive knowledge of agricultural biotechnology to transform the natural power of enzymes into safe, economical and sustainable animal nutrition solutions. BRI has successfully developed and commercialized a portfolio of products, including VersazymeTM, ValkeraseTM and Xylamax™. The company’s premier product, Versazyme, has become the leading protease in the global animal nutrition market due to its consistently superior performance across a wide range of feedstuffs. BRI products are developed and manufactured in the U.S. to comply with stringent global quality and safety standards, including GMP and FAMI-QS. For more information on BRI and its high-performance enzyme solutions, please visit http://briworldwide.com/. ### Media Contact: Crossroads PR & Marketing, for BioResource International, Inc. 919.821.2822 email@example.com
BRI was a Silver Level Sponsor at the Annual Meeting of the Poultry Science Association (PSA) held July 14-17 in Corpus Christi, TX and was the exclusive sponsor of the Asia-Pacific Luncheon on Wednesday, July 16.Alongside newly appointed PSA President Todd Applegate, Executive Director Stephen Koenig and other PSA Board Members, BRI CEO Giles Shih welcomed the guests to the luncheon. Said Dr. Shih, "We appreciate the opportunity to host the luncheon for the second year in a row. Many of these guests attending PSA flew great distances to participate in the PSA meeting and we were glad to make them feel welcome and give them a chance to meet each other at the luncheon."
BioResource International, Inc. Granted FAMI-QS Certification for Quality and Safety in Feed Additives
RESEARCH TRIANGLE PARK, N.C.—June 9, 2014 —BioResource International, Inc. (BRI), an agricultural biotechnology company specializing in the research and development of enzymes, has received the European Feed Additives and Premixtures Quality System Certification (FAMI-QS) for its manufacturing facility in Apex, N.C. The audit was conducted by Underwriter’s Laboratories, Inc. and Deutsch Quality Systems (UL-DQS), a global leader in the assessment and certification of quality and safety management systems.
“We aggressively pursued the FAMI-QS certification because it is the highest quality management standard in our market sector,” said Julian Young, Chief Operating Officer, BRI. “We are committed to ensuring the consistent high quality of our products from source to end use. Our manufacturing site is now certified as compliant with both FAMI-QS and GMP, evidence of the importance we place on contributing to a safe and reliable global food chain.”
The FAMI-QS Code of Practice is comprised of regulations that govern the approval and registration of manufacturers of feed additives for use in animal nutrition. It specifies requirements in the areas of quality and feed safety, management systems, traceability and product regulatory compliance. FAMI-QS is the only certification specific to specialty feed ingredients and their mixtures and is designed to ensure compliance with the European Union Feed Hygiene Regulation.
“FAMI-QS is a rigorous, internationally recognized standard, and provides feed mills, meat producers and consumers with a high level of confidence in all of our products and processes.” adds Brian Spencer, Director of Operations, BRI.
About BioResource International, Inc. BioResource International, Inc. is a U.S. based biotechnology company specializing in the research and development of innovative enzyme solutions for animal agriculture. The company is committed to harnessing the natural power of enzymes to create an economically and environmentally sustainable future from farm to fork. With a deep understanding of poultry and swine nutrition, the company has developed three premium enzyme solutions for meat producers including Versazyme® (the leading protease enzyme), Valkerase® and Xylamax™ which are helping producers worldwide economically deliver more food to meet increasing demand. For more information, visit www.BRIworldwide.com